Early Access

10-KPeriod: FY2006

INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2006

Filed February 15, 2007For Securities:ISRG

Summary

Intuitive Surgical, Inc. (ISRG) demonstrated robust growth in 2006, with revenue increasing by 64% to $372.7 million. This growth was primarily driven by the expanding adoption of its da Vinci Surgical System across various specialties, notably urology and gynecology. The company's business model successfully balances capital equipment sales with recurring revenue from instruments, accessories, and service contracts, with recurring revenue constituting 45% of total revenue in 2006. Significant product development included the launch of the da Vinci S Surgical System in early 2006, which contributed substantially to system sales, and the introduction of a high-definition 3-D vision system in early 2007. Financially, Intuitive Surgical reported strong performance with operating income increasing by 56% and substantial cash flow generation. The company ended the year with a healthy cash balance of $330.3 million, providing financial flexibility. The company is strategically focused on establishing da Vinci surgery as the standard of care for complex procedures and continues to invest in research and development to enhance its technology and expand its product offerings. Key risks include market acceptance, competition, and regulatory hurdles, though the company is actively managing these challenges.

Key Highlights

  • 1Revenue grew 64% to $372.7 million in 2006, driven by increased adoption of the da Vinci Surgical System.
  • 2Recurring revenue (instruments, accessories, service, training) grew 62% to $166.8 million, representing 45% of total revenue.
  • 3170 da Vinci Surgical Systems were sold in 2006, a 48% increase from 2005, with the da Vinci S Surgical System accounting for most sales.
  • 4Operating income increased by 56% to $107.4 million, with a strong operating margin of 29% of revenue.
  • 5The company ended 2006 with $330.3 million in cash, cash equivalents, and investments, indicating robust liquidity.
  • 6Focus on key procedures like da Vinci Prostatectomy (dVP) and da Vinci Hysterectomy (dVH) continues to drive growth.
  • 7Launched the da Vinci S Surgical System in January 2006, which was well-received, and introduced a new high-definition 3-D vision system in early 2007.

Frequently Asked Questions